SOUTH
SAN FRANCISCO, Calif., Jan. 3, 2023
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a
synthetic lethality focused precision medicine oncology company
committed to the discovery and development of targeted
therapeutics, announced its participation at the 41st
Annual J.P. Morgan Healthcare Conference.
J.P. Morgan 41st Annual Healthcare Conference
Tuesday, January 10, 2023 at
4:30 pm PT (7:30 pm ET)
- Presentation by Yujiro S. Hata, Chief Executive Officer
followed by analyst-hosted Q&A with Anupam Rama, Managing Director, US SMID
Biotechnology Equity Research, J.P. Morgan
A live audio webcast of the event will be available, as
permitted by conference host, at the "Investors/ Events" section of
the IDEAYA website at https://ir.ideayabio.com/events. A replay of
the webcast will be accessible for 30 days following the live
event.
__________________
About IDEAYA Biosciences
IDEAYA is a synthetic lethality-focused precision medicine
oncology company committed to the discovery and development of
targeted therapeutics for patient populations selected using
molecular diagnostics. IDEAYA's approach integrates capabilities in
identifying and validating translational biomarkers with drug
discovery to select patient populations most likely to benefit from
its targeted therapies. IDEAYA is applying its early research and
drug discovery capabilities to synthetic lethality – which
represents an emerging class of precision medicine
targets.
__________________
Forward-Looking
Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to participation
in and/or presentation at certain investor relations events. IDEAYA
undertakes no obligation to update or revise any forward-looking
statements. For a further description of the risks and
uncertainties that could cause actual results to differ from those
expressed in these forward-looking statements, as well as risks
relating to the business of IDEAYA in general, see IDEAYA's
Quarterly Report on Form 10-Q filed on November 8, 2022 and any current and periodic
reports filed with the U.S. Securities and Exchange Commission.
___________________
Investor and Media Contact
IDEAYA Biosciences
Paul Stone
Senior Vice President and Chief Financial Officer
investor@ideayabio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-on-tuesday-january-10-2023-301711516.html
SOURCE IDEAYA Biosciences, Inc.